Piper Sandler Companies

Marex Group plc to Participate in Upcoming Piper Sandler Global Exchange & FinTech Conference

Retrieved on: 
星期五, 五月 31, 2024
Conference, Fintech, Piper Sandler Companies, Webcast

NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’), a diversified global financial services platform, today announces that it will be hosting a fireside chat at Piper Sandler's Global Exchange & FinTech Conference.

Key Points: 
  • NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’), a diversified global financial services platform, today announces that it will be hosting a fireside chat at Piper Sandler's Global Exchange & FinTech Conference.
  • The presentation will be given by Ian Lowitt, Group Chief Executive Officer and will take place on Wednesday, June 5th at 9:00 a.m.
  • ET.
  • The fireside chat will be available via webcast and can be accessed here:

Forge Global CEO to Fireside Chat at the Piper Sandler & Co. Global Exchange & Trading Conference

Retrieved on: 
星期四, 五月 30, 2024
Finance, Data Management, Professional Services, Technology, Software, Conference, Piper Sandler Companies

Forge Global Holdings, Inc. (“Forge,” or the “Company”) (NYSE: FRGE), a leading private securities marketplace, today announced that Kelly Rodriques, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler & Co.

Key Points: 
  • Forge Global Holdings, Inc. (“Forge,” or the “Company”) (NYSE: FRGE), a leading private securities marketplace, today announced that Kelly Rodriques, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler & Co.
  • Global Exchange & Trading Conference.
  • Details for the event are as follows:
    Where: Piper Sandler & Co.
  • Global Exchange & Trading Conference, New York, NY.

Piper Sandler Strengthens Energy & Power Investment Banking with the Addition of Ryan Tull

Retrieved on: 
星期一, 五月 13, 2024
Banking, Fintech, Professional Services, Finance, Piper Sandler Companies, Credit Suisse, J. P. Morgan, Cryptocurrency

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Ryan Tull as a managing director on the energy & power investment banking team.

Key Points: 
  • Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Ryan Tull as a managing director on the energy & power investment banking team.
  • Tull will focus on oilfield services & equipment, energy & power infrastructure and energy technology.
  • “Ryan is an experienced banker that will bring significant market knowledge and a strong personal network to further enable successful transactions for our clients in the M&A advisory and capital markets segments,” said Sanjiv Shah , global co-head of energy & power investment banking at Piper Sandler.
  • “Through the addition of Ryan, we are continuing to expand our energy and power franchise at Piper Sandler and everyone is excited to have him join the team.

Piper Sandler Strengthens Technology Investment Banking with the Additions of Rob Freiman and Kegan Greene

Retrieved on: 
星期一, 四月 29, 2024
Professional Services, Technology, Other Technology, Finance, Fintech, Banking, Freimann, Jefferies Financial Group, Jefferies, Insurance, Knowledge, Piper Sandler Companies

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of Rob Freiman and Kegan Greene as managing directors on the technology investment banking team.

Key Points: 
  • Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of Rob Freiman and Kegan Greene as managing directors on the technology investment banking team.
  • “We are actively building our technology franchise at Piper Sandler and we are very excited to welcome Rob and Kegan to the team.
  • Rob and Kegan have worked together for years and have a long and successful track record of providing advisory services to fintech clients,” said Brian White , co-head of technology investment banking at Piper Sandler.
  • Prior to joining Piper Sandler, Freiman and Greene co-led the U.S. financial technology investment banking effort at Jefferies Financial Group Inc., where Freiman was head of payments investment banking and Greene was head of insurance technology investment banking.

Mr. Cooper Group Announces Two New Senior Leaders

Retrieved on: 
星期二, 四月 23, 2024
Residential Building & Real Estate, Construction & Property, Professional Services, Finance, Bhattacharya (surname), Corporate finance, Wells Fargo, Capital market, EVP, Correspondent, Research, Piper Sandler Companies, Senior, COOP, Growth, Management

Mr. Cooper Group Inc. (NASDAQ: COOP) announced today the appointment of two new senior leaders.

Key Points: 
  • Mr. Cooper Group Inc. (NASDAQ: COOP) announced today the appointment of two new senior leaders.
  • Kevin Barker assumed the role of Senior Vice President, Corporate Finance on April 22, 2024, leading the company’s business finance teams and reporting to Chief Financial Officer Kurt Johnson.
  • “Ranjit’s deep knowledge of capital markets and correspondent lending and Kevin’s extensive understanding of the mortgage industry will undoubtedly bring new ideas and insights to Mr. Cooper,” said Jay Bray, Chairman and CEO of Mr. Cooper Group.
  • Prior to Wells Fargo, Bhattacharjee held senior leadership positions at Citi Mortgage and Caliber Home Loans.

Leerink Partners Adds Industry Veteran Andrew Gitkin to Healthcare Investment Banking Team

Retrieved on: 
星期四, 四月 25, 2024
Piper Sandler Companies, Senior, Moelis & Company, SVB Securities, Investment banking, Biotechnology, Ophthalmology, Health, Raymond James Financial

BOSTON, April 25, 2024 /PRNewswire/ -- Leerink Partners, a leading investment bank specializing in healthcare, today announced the addition of Andrew Gitkin as Senior Managing Director, Investment Banking.

Key Points: 
  • BOSTON, April 25, 2024 /PRNewswire/ -- Leerink Partners, a leading investment bank specializing in healthcare, today announced the addition of Andrew Gitkin as Senior Managing Director, Investment Banking.
  • Mr. Gitkin brings over 25 years of experience in healthcare investment banking, specializing in mergers and acquisitions with a focus on ophthalmology and robotic surgery.
  • Mr. Gitkin will be based in the firm's Miami office and will report to Dr. Dan Dubin, Global Co-Head of Investment Banking.
  • Prior to joining Leerink Partners, Mr. Gitkin served as a Senior Managing Director and Vice Chairman at Raymond James & Associates, co-leading the U.S. healthcare investment banking group.

Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024

Retrieved on: 
星期二, 四月 9, 2024
Therapy, SAN, Liver, Piper Sandler Companies

SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that management will participate in one-on-one meetings at the Piper Sandler Spring Biopharma Symposium 2024 being held in Boston, Massachusetts on April 16-17, 2024.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that management will participate in one-on-one meetings at the Piper Sandler Spring Biopharma Symposium 2024 being held in Boston, Massachusetts on April 16-17, 2024.
  • Please contact your Piper Sandler representative to schedule a one-on-one meeting.

Praxis Precision Medicines to Participate in Upcoming April Conferences

Retrieved on: 
星期五, 四月 5, 2024
Praxis, Central nervous system, Webcast, CNS, Conference, Piper Sandler Companies

BOSTON, April 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will take part in upcoming conferences in April.

Key Points: 
  • BOSTON, April 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will take part in upcoming conferences in April.
  • Praxis management will participate in a fireside chat at the Needham 23rd Annual Healthcare Conference, taking place virtually on April 8, 2024 at 8:00a.m EDT.
  • A replay of the webcast will be available on Praxis’ website for 90 days following the event.
  • Management will also participate in the Piper Sandler Spring Biopharma Symposium, taking place in Boston, MA on April 16-17, 2024.

ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium

Retrieved on: 
星期三, 四月 3, 2024
Encore Boston Harbor, ANI, Piper Sandler Companies

BAUDETTE, Minn., April 03, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will host investor meetings at the Piper Sandler Spring Biopharma Symposium on Wednesday, April 17, 2024, at the Encore Boston Harbor.

Key Points: 
  • BAUDETTE, Minn., April 03, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will host investor meetings at the Piper Sandler Spring Biopharma Symposium on Wednesday, April 17, 2024, at the Encore Boston Harbor.
  • To schedule a 1x1 meeting with the Company, please email [email protected] .

Inari Medical, Inc. (NARI) Plummets on News of DOJ Investigation – Hagens Berman

Retrieved on: 
星期一, 四月 1, 2024
NARI, Medicine, Health, Piper Sandler Companies, News, Person, Disclosure, DOJ, Justice, Hagens Berman, Pharmaceutical industry

Inari Medical shares recently tumbled after the commercial-stage medical device company disclosed it was being investigated by the DOJ over certain payments to healthcare professionals.

Key Points: 
  • Inari Medical shares recently tumbled after the commercial-stage medical device company disclosed it was being investigated by the DOJ over certain payments to healthcare professionals.
  • But on Feb. 29, 2024, the true drivers of Inari’s revenue growth came into question, when Inari revealed that federal regulators had initiated an investigation into its payments to Health Care Professionals (“HCPs”) sometime during Dec. 2023.
  • This news sent the price of Inari shares crashing $12.14, or down about 21%, on Feb. 29, 2024.
  • “We are investigating the propriety of Inari’s touted revenue growth and repeated claims that its strategy had positioned it for sustained operating profitability by the first half of 2025,” said Reed Kathrein, the Hagens Berman partner leading the investigation.